Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?

This publication has 10 references indexed in Scilit:

• May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
  Medical Hypotheses, 2020
• Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
  Microbes and Infection, 2020
• 5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety
  Dermatologic Therapy, 2020
• What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
  Dermatologic Therapy, 2020
• The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
  Advances in Urology, 2011
• Androgen receptor and androgen-dependent gene expression in lung
  Molecular and Cellular Endocrinology, 2010
• Gene expression profile of androgen modulated genes in the murine fetal developing lung
  Reproductive Biology and Endocrinology, 2010
• Trans-differentiation of Alveolar Epithelial Type II Cells to Type I Cells Involves Autocrine Signaling by Transforming Growth Factor β1 through the Smad Pathway
  Journal of Biological Chemistry, 2007
• Androgen Inactivation in Human Lung Fibroblasts: Variations in Levels of 17β-Hydroxysteroid Dehydrogenase Type 2 and 5α-Reductase Activity Compatible with Androgen Inactivation
  The Journal of Clinical Endocrinology & Metabolism, 2002
• Alveolar type II cell-fibroblast interactions, synthesis and secretion of surfactant and type I collagen
  Journal of Cell Science, 1993